Developer of life science tools Bruker Daltonics has introduced a
new research instrument for proteomics research at the laboratory
science exhibition Pittcon, taking place in the US this week.
In its first progress report since adopting the EU strategy on life
sciences and biotechnology in 2002, the European Commission
yesterday indicated that the risk of diverging policies in Member
States could seriously hamper the effectiveness...
Drug development and biomedical company Thuris and Italian
pharmaceutical company Sigma-Tau Industrie Farmaceutiche Riunite on
Monday announced an expansion of their ongoing research
collaboration to develop compounds to combat brain...
An Edinburgh-based marine biotech business has been given a £50,000
(€73 000) boost in its bid to scour tidal areas such as rock pools
to find and develop new drugs and antibiotics, including a new
compound found to be active against...
In the second news of the day on a European life science company,
DSM announced this week that from now on it will supply
technologies and services for the initial development phases of new
medicines - supplementing its existing service...
Japanese company Kaken Pharmaceutical and US Elitra Pharmaceuticals
said yesterday that they are to collaborate on a multi-year
research project for the discovery and development of novel
anti-fungal drugs.
US demand for combinatorial chemistry products and services is set
to increase by more than twelve per cent annually to reach $4
billion (€3.7bn) in 2006, according to a new report from market
analyst the Freedonia group.
US company Biolog this week received a patent for its Phenotype
MicroArray technology. The patent, number US 6,472,201, is granted
for comparative phenotypic analysis of two or more microorganisms
using a number of substrates within...
Drug discovery company Pharmacopeia and healthcare business
AstraZeneca have extended their research collaboration. The
companies announced this week that they will shift their efforts
from the generation of screening libraries to...
3-Dimensional Pharmaceuticals (3DP) said this week that the
research term under its thrombin collaboration with two of the
Johnson & Johnson family of companies, Centocor and Johnson
& Johnson Pharmaceutical Research and Development,...
Combinatorial technology company Symyx Technologies reports today
that revenue for 2002 had increased to $64.8 million (€59m)
compared with $60.0 million in 2001.
US Pharmacopeia has entered into a research collaboration focused
on inflammation with Celgene Corporation. The companies will work
together to identify promising small molecule lead compounds
suitable for further development.
Large Scale Biology Corporation (LSBC) has started a research
collaboration with Novozymes Biotech to apply LSBC's gene shuffling
and molecular evolution technologies to genes of interest to
Novozymes Biotech.
The chemical cousin of vitamin A is thought to restore production
of a key protein, which has been damaged by cigarettes in the lungs
of former smokers, and protects the cells against lung cancer,
according to new findings published...
Two suppliers to the life sciences industry, Amersham Biosciences
and Thermo Electron are to jointly market and sell mass
spectrometry-based proteomics solutions for protein scientists.
Genicon Sciences this week launched its second Resonance Light
Scattering (RLS) technology product - an RLS-based two-colour
nucleic Acid microarray toolkit for gene expression analysis.
Genetronics Biomedical has completed the sale its BTX division to
Harvard Bioscience for $3.7 million. Genetronics Biomedical's
stockholders approved the sale in a meeting on Friday.
High Content Screening company Cellomics announced today that the
Canadian Intellectual Property Office has issued Cellomics'
Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based
Screening.'
In relation to recent media comments relating to its
commercialisation discussions UK company GW Pharmaceuticals said in
a statement this week that it has consistently stated its
commercial strategy 'to be to enter into partnerships...
The structure of a key energy-releasing enzyme found in all animals
is designed to minimise free radical production, an international
team of researchers report in this week's Science.
German LION bioscience has launched an integration platform that
aims to speed up drug discovery by integrating cross-functional
information from a variety of databases and applications
Canadian drug development company Ecopia BioSciences on Monday
announced that it had filed patent applications for the first two
novel compounds using its proprietary drug discovery platform -
suggesting investments by the company...
US company Molecular Devices, a supplier of bioanalytical
measurement systems, announced its revenues and earnings for the
quarter and year ended 31 December, 2002. Revenues for the fourth
quarter of 2002 were a healthy $30.2 million,...
